Survival benefit of extracorporeal membrane oxygenation in severe COVID-19: a multi-centre-matched cohort study

PURPOSE: Extracorporeal membrane oxygenation (ECMO) has become an established therapy for severe respiratory failure in coronavirus disease 2019 (COVID-19). The added benefit of receiving ECMO in COVID-19 remains uncertain. The aim of this study is to analyse the impact of receiving ECMO at speciali...

Descripción completa

Detalles Bibliográficos
Autores principales: Whebell, Stephen, Zhang, Joe, Lewis, Rebecca, Berry, Michael, Ledot, Stephane, Retter, Andrew, Camporota, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892395/
https://www.ncbi.nlm.nih.gov/pubmed/35238946
http://dx.doi.org/10.1007/s00134-022-06645-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892395/
https://www.ncbi.nlm.nih.gov/pubmed/35238946
http://dx.doi.org/10.1007/s00134-022-06645-w

Ejemplares similares